Home » Newsletters » BioWorld Science

BioWorld Science

March 16, 2000

View Archived Issues

Advanced Tissue Sciences restructures joint venture for Dermagraft during Q4

Lundbeck highlights significant events during 1999

Lilly files NDA for new formulation of Prozac for depression

IND filed by NeoPharm for glioblastoma treatment

Isotechnika receives Canadian approval for human testing of immunosuppressive drug

CytRx to continue Flocor development as treatment for sickle cell disease

Aventis launches new antibiotic in Canada

Anesta renegotiates U.S. marketing rights for Actiq with Abbott

Multiple-dose clinical study of Betabloc as Alzheimer's therapy to begin soon

EGF receptor tyrosine kinase inhibitor selected for clinical testing at Parke-Davis

Otsuka prepares new orally active analgesic agents

Maleimide PKC inhibitors designed by Japan Tobacco

New agents for insulin resistance syndrome in the Merck pipeline

Meiji Seika discloses wide series of carbapenems and orally bioavailable esters

Neurocrine Biosciences' GnRH antagonist program advances

Rhein Biotech aims to become a world leader in vaccines with GCV acquisition

Selective glucocorticoid receptor modulators discovered by Abbott

Ampakine-like compounds for psychiatric and neurological disorders

Antiepileptic agents under study at Arzneimittelwerk Dresden

Potent, selective c-Src TK inhibitor identified using new target-based method

BOM-1006 selected as a lead benzimidazole for the development of antiallergic agents

Schering-Plough to copromote Tequin in U.S.; Tequin evaluated in PROVE IT trial

New use for teprenone in myocardial preconditioning? Evidence presented at ACC meeting

Continued treatment with Enbrel safe and effective in chronic heart failure

Nicostatin effective for increasing "good" cholesterol, lowering "bad" cholesterol

Monsanto and Pharmacia & Upjohn proceed towards completion of merger

Novel features of H-345/52 indicate promising activity in tachyarrhythmia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...